|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 397.55 USD | -3.65% |
|
-14.57% | +68.95% |
| 12-11 | Markets Wanted a Party. The Economy Brought a Reality Check. |  |
| 12-11 | Alnylam announces partial repurchase of 1.00% convertible senior notes due 2027 | RE |
EPS & Dividend: Alnylam Pharmaceuticals, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.46 | -7.2 | -9.3 | -3.52 | -2.18 | 2.281 | 7.078 | 12.94 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 129.97 | 169.58 | 237.65 | 191.41 | 235.31 | 412.63 | 412.63 | 412.63 |
| Nbr of stocks (in thousands) | 116,181 | 119,601 | 123,028 | 125,493 | 128,981 | 132,114 | - | - |
| Announcement Date | 11/02/21 | 10/02/22 | 23/02/23 | 15/02/24 | 13/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Alnylam Pharmaceuticals, Inc.
| 11/02/2026 | Q4 2025 Earnings Release (Projected) |
| 29/04/2026 | Q1 2026 Earnings Release (Projected) |
| 29/07/2026 | Q2 2026 Earnings Release (Projected) |
| 28/10/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | 180.94x | 65.19x | 14.13x | |
| 0.59% | 0.66% | 44.13x | 33.23x | 14.61x | |
| 2.46% | 2.54% | 20.04x | 6.44x | 5.62x | |
| 2.91% | 3.04% | 52.26x | 3761.21x | 7.42x | |
| 3.11% | 3.17% | 18.45x | 6.58x | 4.63x | |
| 1.77% | 1.86% | 27.47x | 6.2x | 5.2x | |
| 3.06% | 3.19% | 18.42x | 5.77x | 4.97x | |
| 3.27% | 3.31% | 12.79x | 4.56x | 4.19x | |
| 3.64% | 3.57% | 13.86x | 7.53x | 4.96x | |
| 3.01% | 3.18% | 25.01x | 19.18x | 5.93x | |
| Average | 2.38% | 2.45% | 41.34x | 391.59x | 7.17x | |
| Weighted average by Cap. | 2.19% | 2.27% | 32.50x | 454.63x | 8.05x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition